Share price weakness opens up a buying
opportunity
Our view: We believe the shares of Enercare were oversold on the back
of weaker-than-expected Q1 results. A large part of the Q1 miss was
due to the mild winter and one-time items, and our investment thesis is
unchanged. We are reiterating our Outperform rating and see the share
price weakness as a near-term buying opportunity